Neochromosome, Inc.
Thomas DesMarais is a highly skilled scientist specializing in mammalian cell engineering and genome editing at Neochromosome, Inc. since May 2021. Prior to this role, Thomas contributed as a protein engineer at Ordaos Bio from May 2020 to March 2021 and held various positions, including research scientist, graduate assistant, and Ph.D. candidate at NYU Langone Health from August 2013 to July 2019. Thomas earned a Doctor of Philosophy (Ph.D.) in Systemic Toxicology from New York University between 2015 and 2019, complemented by a Master of Science (MS) in Environmental Health from the same institution (2013-2015), and a Bachelor's of Science in Biology from Marist College (2009-2013).
This person is not in any teams
Neochromosome, Inc.
At Neochromosome, we enable biological engineering at a genome-scale. Our partners use our groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct pioneering scientific research. Neochromosome is uniquely suited to accelerate this work. Our first-in-class capabilities were developed to design, build, and test the world's first fully synthetic eukaryotic cells. Today, we offer our services and platform -- from highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes – to researchers around the world.